Fetal Hemoglobin (HbF) Induction during Initial Decitabine (DAC) Treatment of Elderly High-Risk MDS and AML Patients: A Potential Dynamic Biomarker for Outcome

被引：0
|
作者：
Stomper, Julia
Ihorst, Gabriele
Suciu, Stefan
Sander, Philipp Nikolaus
Becker, Heiko
Wijermans, P. W.
Bisse, Emmanuel
Claus, Rainer
Lubbert, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4261
引用
收藏
页数：3
相关论文
共 14 条
  • [1] Fetal hemoglobin induction during decitabine treatment of elderly high-risk MDS and AML patients: A potential dynamic biomarker for outcome
    Stomper, J.
    Ihorst, G.
    Suciu, S.
    Sander, P. N.
    Becker, H.
    Wijermans, P. W.
    Bisse, E.
    Claus, R.
    Luebbert, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 19 - 19
  • [2] Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome
    Stomper, Julia
    Ihorst, Gabriele
    Suciu, Stefan
    Sander, Philipp N.
    Becker, Heiko
    Wijermans, Pierre W.
    Plass, Christoph
    Weichenhan, Dieter
    Bisse, Emmanuel
    Claus, Rainer
    Luebbert, Michael
    [J]. HAEMATOLOGICA, 2019, 104 (01) : 59 - 69
  • [3] Effects of decitabine, combined with all-trans retinoic acid or valproate, on fetal hemoglobin (HbF) induction in elderly AML patients
    Stomper, J.
    Bisse, E.
    Luebbert, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 89 - 89
  • [4] Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients
    Gardner, Kelda
    Estey, Elihu H.
    Tong, Weigang
    McCroskey, Robert
    Walter, Roland B.
    Hendrie, Paul C.
    Scott, Bart L.
    Perdue, Andrea M.
    Percival, Mary-Elizabeth M.
    Smith, Heather A.
    Hammer, Cody
    Becker, Pamela S.
    [J]. BLOOD, 2016, 128 (22)
  • [5] Elevated Pre-Treatment Fetal Hemoglobin Predicts Better Outcome in MDS/AML Patients Receiving 5-Aza-2'-Deoxycytidine (DAC)
    Claus, Rainer
    Ihorst, Gabriele
    Sander, Philipp
    Bogatyreva, Ljudmila
    Becker, Heiko
    Wijermans, Pierre W.
    Suciu, Stefan
    Bisse, Emmanuel
    Lubbert, Michael
    [J]. BLOOD, 2016, 128 (22)
  • [6] Methylation Patterns of Fetal Hemoglobin Regulating Genes in High-Risk (HR) -MDS Patients Following Treatment with Azacytidinee
    Chatzilygeroudi, Theodora
    Chondrou, Vasiliki
    Athanasopoulou, Katerina
    Alexis, Spyridon
    Verigou, Evgenia
    Sgourou, Argyro
    Symeonidis, Argiris S.
    [J]. BLOOD, 2023, 142
  • [7] Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
    Janssen, Jeroen
    Lowenberg, Bob
    Manz, Markus
    Bargetzi, Mario
    Biemond, Bart
    Borne, Peter von Dem
    Breems, Dimitri
    Brouwer, Rolf
    Chalandon, Yves
    Deeren, Dries
    Efthymiou, Anna
    Gjertsen, Bjorn-Tore
    Graux, Carlos
    Gregor, Michael
    Heim, Dominik
    Hess, Urs
    Hoogendoorn, Mels
    Jaspers, Aurelie
    Jie, Asiong
    Jongen-Lavrencic, Mojca
    Klein, Saskia
    van der Klift, Marjolein
    Kuball, Jurgen
    van Lammeren-Venema, Danielle
    Legdeur, Marie-Cecile
    van de Loosdrecht, Arjan
    Maertens, Johan
    Kooy, Marinus van Marwijk
    Moors, Ine
    Nijziel, Marten
    van Obbergh, Florence
    Oosterveld, Margriet
    Pabst, Thomas
    van der Poel, Marjolein
    Sinnige, Harm
    Spertini, Olivier
    Terpstra, Wim
    Tick, Lidwine
    van der Velden, Walter
    Vekemans, Marie-Christiane
    Vellenga, Edo
    de Weerdt, Okke
    Westerweel, Peter
    Stussi, Georg
    van Norden, Yvette
    Ossenkoppele, Gert
    [J]. CANCERS, 2021, 13 (04) : 1 - 11
  • [8] Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
    Wu, Lingyun
    Li, Xiao
    Su, Jiying
    He, Qi
    Zhang, Xi
    Chang, Chunkang
    Pu, Quan
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1563 - 1569
  • [9] Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
    Lingyun Wu
    Xiao Li
    Jiying Su
    Qi He
    Xi Zhang
    Chunkang Chang
    Quan Pu
    [J]. Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1563 - 1569
  • [10] Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011.
    Luebbert, Michael
    Suciu, Stefan
    Hagemeijer, Anne
    Bogatyreva, Ljudmila
    Rueter, Bjoern
    Platzbecker, Uwe
    Giagounidis, Aristoteles
    Selleslag, Dominik
    Labar, Boris
    Germing, Ulrich
    Salih, Helmut R.
    Meert, Liv
    Muus, Petra
    Pflueger, Karl-Heinz
    Kuendgen, Andrea
    Aul, Carlo
    de Witte, Theo M.
    Ganser, Arnold
    Marie, Jean-Pierre
    Wijermans, Pierre W.
    [J]. BLOOD, 2012, 120 (21)
12